Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | USP17L29 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | MTF2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | FOSL1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | EVI5 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | CIC | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | ZIK1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | RP11-949J7.8 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | PODXL2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | TULP1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | CD164 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |